Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Glaucoma
Retina
Blindness study
 
 
Survey

Did you attend AAO 2013?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.


November 27, 2013
Glaucoma therapy
Investigational ROCK inhibitor has positive clinical results
Researchers presented positive top-line clinical results for AMA0076 (Amakem Therapeutics), a possible new drug candidate for the treatment of glaucoma at the 2013 annual meeting of the American Academy of Ophthalmology. More...
Retina research
Protein from fat-derived stem cells may prevent retinal damage
Progranulin, a protein found in fat-derived stem cells, may reverse and perhaps prevent age-related, light-induced retinal damage, according to results from a study done in a mouse model by researchers from Gifu Pharmaceutical University and Gifu University, Japan. More...
Global blindness study
Worldwide causes of blindness mapped
Major geographical differences exist worldwide in cases of cataracts and macular degeneration, according to the largest-ever analysis of worldwide vision impairment and blindness, which was recently published. More...
Choosing and using the AcrySof IQ ReSTOR IOL family
Customize
d options for individual patients. Read more:
The Safety of anti-VEGF Therapy
Under the microscope, in trials and in clinical practice. Read more: